Objective. The Canadian Vasculitis research network (CanVasc) is composed of physicians
from different medical specialties and researchers with expertise in vasculitis. One of its aims …

Objective To develop and validate revised classification criteria for granulomatosis with
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into …

Objective To develop and validate revised classification criteria for eosinophilic granulomatosis
with polyangiitis (EGPA). Methods Patients with vasculitis or comparator diseases were …

Objective To develop and validate classification criteria for microscopic polyangiitis (MPA).
Methods Patients with vasculitis or comparator diseases were recruited into an international …

Objective To develop and validate new classification criteria for Takayasu arteritis (TAK).
Methods Patients with vasculitis or comparator diseases were recruited into an international …

Objective. The rarity of large vessel vasculitis (LVV) is a major factor limiting randomized
controlled trials in LVV, resulting in treatment choices in these diseases that are guided mainly …

Objective In 2020, the Canadian Vasculitis Research Network (CanVasc) published their
updated recommendations for the management of ANCA-associated vasculitides (AAV). The …

Objectives To finalise and validate a disease-specific patient-reported outcome (PRO)
measure: the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire. …

Objective In 2015, the Canadian Vasculitis Research Network (CanVasc) created
recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated …

OBJECTIVE: Explore the potential use of a cytokine panel as biochemical markers of
disease activity in rheumatoid arthritis (RA) patients. DESIGN AND METHODS: 57 adult RA …